SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-007538
Filing Date
2017-05-18
Accepted
2017-05-18 18:02:28
Documents
1
Period of Report
2017-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3039
  Complete submission text file 0001179110-17-007538.txt   4440
Mailing Address THERAVANCE, INC. 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Fore Henrietta (Reporting) CIK: 0001503774 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 17855976

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations